Intracardiac or intrapulmonary shunts were present in at least 35% of adults with homozygous sickle cell disease followed in an outpatient clinic.

Autor: Hambley BC; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University Hospitals Cleveland Medical Center (UHCMC) and Case Western Reserve University (CWRU)., Rahman RA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University Hospitals Cleveland Medical Center (UHCMC) and Case Western Reserve University (CWRU)., Reback M; Division of Internal Medicine, Department of Medicine, UHCMC and CWRU., O'Riordan MA; Department of Pediatrics, Rainbow Baby and Children's Hospital and CWRU., Langer N; Division of Hematology and Oncology, Department of Medicine, UHCMC and CWRU., Gilkeson RC; Division of Cardiothoracic Imaging, Department of Radiology, UHCMC and CWRU., Ginwalla M; Division of Cardiovascular Medicine, Department of Medicine, UHCMC and CWRU, Cleveland, OH, USA., Little JA; Division of Hematology and Oncology, Department of Medicine, UHCMC and CWRU Jane.little@uhhospitals.org robert.schilz@uhhospitals.org., Schilz R; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University Hospitals Cleveland Medical Center (UHCMC) and Case Western Reserve University (CWRU) Jane.little@uhhospitals.org robert.schilz@uhhospitals.org.
Jazyk: angličtina
Zdroj: Haematologica [Haematologica] 2019 Jan; Vol. 104 (1), pp. e1-e3. Date of Electronic Publication: 2018 Jul 13.
DOI: 10.3324/haematol.2018.196212
Databáze: MEDLINE